PBKM started cooperation with Dystrogen Therapeutics
The Polish Stem Cell Bankestablished cooperation with the biotechnology company Dystrogen Therapeutics. The agreement will enable joint research on chimeric cells and PBKM’s production of ATMP stem cells based medicinal products – PBKM informed in a press release. Dystrogen Therapeutics SA was founded in 2017 by prof. Maria Siemionow and Dr. Kris Siemionow. “We are […]
FamiCord is number 1 in Europe and number 5 in the World
We are very happy to announce that according to data of Parent’s Guide to Cord Blood Foundation, FamiCord group is the biggest European cord blood bank and 5th biggest CB bank in the world. That means that parents trust our brand and choose us as a parter for years. That proves, we are heading into […]
Portugese stem cell bank Bebecord is now a part of FamiCord Group
Stemlab, a company owned by Polski Bank Komórek Macierzystych (Polish Stem Cell Bank) takes over Bebecord – a Portuguese stem cell bank. This is the second stem cell bank in Portugal in the family of FamiCord banks.Stemlab, a company owned by Polski Bank Komórek Macierzystych (Polish Stem Cell Bank) takes over Bebecord – a Portuguese stem cell bank. This […]
Innovative therapy for FamiCord Group Clients
FamiCord Group Expanded Access ProtocolCord Blood for Cerebral Palsy Information for the Parent FamiCord Group’s Treatment Program is a Breakthroughin the Use of the Patients’ Own Stem Cells FamiCord Group launches a treatment program of using autologous cord blood stem cells in treating cerebral palsy. It means that patients from all of Europe will have access to innovative […]
Letter of intent between Medical University of Warsaw (WUM) and FamiCordTx signed
Rector of the Medical University of Warsaw prof. Mirosław Wielgoś and representatives of the FamiCordTx company: Dr Tomasz Baran – President of the Management Board and Dr Tomasz Ołdak – Member of the Management Board – signed a letter of intent regarding cooperation in the field of development and implementation of immunotherapy as an innovative cancer […]
The FamiCord Group strengthens its position in Turkey
The FamiCord Group strengthens its position in Turkey by investing in a stem cell bank belonging to the Acıbadem Healthcare Group FamiCord Group has concluded an investment agreement regarding the purchase of shares in the Turkish stem cell bank which has operated so far within the structure of the Acıbadem Healthcare Group. FamiCord group has now […]
Multiplication of umbilical cord blood stem cells as a chance for cancer patients
Multiplication of umbilical cord blood stem cells as a new hope for cancer patients Cord blood stem cells are used in medicine for treatment of over 80 different diseases such as leukemias, lymphomas and sickle cell anemia for over 30 years. It has also been proven that in the field of regenerative medicine, the application of […]
First transplantation of autologus cord blood stored in FamiCord Group in hematological disease
At the age of 3, Antek became ill with aplastic anemia. This disease involves damage to the bone marrow, which causes reduced production of red and white blood cells and platelets, leading to anemia. The only solution for patients is a stem cell transplant. At the time of Antek’s illness, his sister was 7 months old […]
Cord blood transplant cures AIDS
In 1996, it was reported that 1% of the Caucasian race population is affected with mutation of CCR gene and that makes these individuals resistant to HIV infection, It was hypothesized that transplantation of hematopoietic stem cells from donors with this mutation to HIV positive patients would cure them. In 2008, at the conference in […]
Autologus cord blood in autism treatment- new clinical trial in Romania
Researchers at Bioforum Foundation have been studying whether intravenous infusions of cord blood stem cells can help young children with autism spectrum disorder (ASD). The leader of this research group is dr Felician Stăncioiu. Dr. Stăncioiu is the lead investigator of a registered clinical trial NCT04007224 named “CORDUS” that is using autologous umbilical cord blood to […]
